HIV, HCV and Related Comorbidities in Rural Communities Affected by Opioid Injection Drug Epidemics in the United States: Building Systems for Prevention, Treatment and Control (UG3/UH3)
Application: Jan 10, 2017
A list of agency contacts is available in the application instructions.
This funding opportunity will support two-stage, multi-method research projects that inform community response and promote comprehensive, integrated approaches to prevent HIV and hepatitis C virus infection, along with associated comorbidities, such as hepatitis B virus infection and sexually transmitted diseases, among people who inject drugs in rural US communities.
The program's primary focus is opioid injection and its consequences. Projects should provide evidence of the effectiveness of community response models and best practices in responding to opioid injection epidemics that can be implemented by public health systems in similar rural communities in the United States.
Eligible applicants include:
- Higher education institutions
- Nonprofit organizations
- For-profit businesses
- Governments, including tribes and territories
- Other public agencies
A detailed list of eligible applicants may be found in the application instructions.
- Budgets for Phase 1 Exploratory/ Developmental (UG3) projects must not exceed $400,000 in direct costs for any year.
- Budgets for Phase II (UH3) projects are not limited but must reflect the actual needs of the proposed project.
Expected Number of Awards: Up to 10-UG3 awards and 8-UH3 awards
Project period: Up to 5 years
While not required, prospective applicants are asked to submit a letter of intent 30 days prior to the application due date. The preferred Letter of Intent submission method is by email to NIDALetterofIntent@mail.nih.gov. The letter may also be mailed to:
Office of Extramural Policy and Review
National Institute on Drug Abuse/NIH/DHHS
6001 Executive Boulevard, Suite 4243, MSC 9550
Bethesda, MD 20892-9550
Links to the full announcement and online application procedures are available through grants.gov.
Note: This opportunity is listed under a single Funding Opportunity Announcement Number, RFA-DA-17-014 , and a series of Catalog of Federal Domestic Assistance (CFDA) Numbers based on research area.
- 93.270 - Adult Viral Hepatitis Prevention and Control
- 93.279 - Drug Abuse and Addiction Research Programs
- 93.941 - HIV Demonstration, Research, Public and Professional Education Projects
For complete information about funding programs, including your application status, please contact funders directly. Summaries are provided for your convenience only. RHIhub does not take part in application processes or monitor application status.